Grantclosed🌐 United StatesRFA-AR-25-014

Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)

National Institutes of Health

Details?

Posted: Jun 17, 2025
Response deadline: Dec 9, 2025, 12:00 AM UTC
Type: Grant
Category: 93.840, 93.838, 93.846, 93.867, 93.233, 93.837, 93.839
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-AR-25-014

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)
United States · Jun 17, 2025
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
United States · Dec 11, 2024
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
United States · Feb 2, 2024
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
United States · Dec 11, 2024
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
United States · Jul 12, 2022
Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
United States · Dec 16, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.